BGLC financials
BioNexus Gene Lab (BGLC) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
- BGLC revenue was $7.42M in fiscal 2025, net income -$2.98M.
BGLC income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $7.42M | $1.09M | -$2.97M | -$2.98M | -1.61 |
| 2024 | $9.51M | $1.29M | -$1.57M | -$1.60M | -0.90 |
| 2023 | $9.77M | $1.33M | -$2.59M | -$2.63M | -0.17 |
| 2022 | $10.93M | $1.26M | -$291.18K | -$355.97K | – |
| 2021 | $13.36M | $2.27M | $1.06M | $751.57K | – |
| 2020 | $11.39M | $1.72M | $1.27M | $1.09M | 0.01 |